Patents by Inventor Richard Boyd White

Richard Boyd White has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pharmaceutical preparation
    Patent number: 11952407
    Abstract: Preparations including recombinant FSH (rFSH).
    Type: Grant
    Filed: April 30, 2021
    Date of Patent: April 9, 2024
    Assignee: FERRING INTERNATIONAL CENTER S.A.
    Inventors: Ian Cottingham, Daniel Plaksin, Richard Boyd White
  • PHARMACEUTICAL PREPARATION
    Publication number: 20210332099
    Abstract: Preparations including recombinant FSH (rFSH).
    Type: Application
    Filed: April 30, 2021
    Publication date: October 28, 2021
    Applicant: Ferring International Center SA
    Inventors: Ian COTTINGHAM, Daniel PLAKSIN, Richard Boyd WHITE
  • Pharmaceutical preparation
    Patent number: 10995128
    Abstract: Preparations including recombinant FSH (rFSH).
    Type: Grant
    Filed: August 29, 2017
    Date of Patent: May 4, 2021
    Assignee: FERRING INTERNATIONAL CENTER SA
    Inventors: Ian Cottingham, Daniel Plaksin, Richard Boyd White
  • Pharmaceutical preparation comprising recombinant HcG
    Patent number: 10526390
    Abstract: The present disclosure describes recombinant human chorionic gonadotropin (hCG) and methods for the production thereof. The recombinant hCG can include ?2,3, ?2,6, and, optionally, ?2,8 sialylation. The recombinant hCG can be produced in a human cell line such as a PER.C6® cell line.
    Type: Grant
    Filed: May 3, 2017
    Date of Patent: January 7, 2020
    Assignee: FERRING B.V.
    Inventors: Ian Cottingham, Daniel Plaksin, Richard Boyd White
  • PHARMACEUTICAL PREPARATION
    Publication number: 20180079794
    Abstract: Preparations including recombinant FSH (rFSH).
    Type: Application
    Filed: August 29, 2017
    Publication date: March 22, 2018
    Inventors: Ian Cottingham, Daniel Plaksin, Richard Boyd White
  • Pharmaceutical Preparation Comprising Recombinant HcG
    Publication number: 20180030107
    Abstract: The present disclosure describes recombinant human chorionic gonadotropin (hCG) and methods for the production thereof. The recombinant hCG can include ?2,3, ?2,6, and, optionally, ?2,8 sialylation. The recombinant hCG can be produced in a human cell line such as a PER.C6® cell line.
    Type: Application
    Filed: May 3, 2017
    Publication date: February 1, 2018
    Inventors: Ian Cottingham, Daniel Plaksin, Richard Boyd White
  • Pharmaceutical preparation
    Patent number: 9771407
    Abstract: Preparations including recombinant FSH (rFSH).
    Type: Grant
    Filed: August 16, 2016
    Date of Patent: September 26, 2017
    Assignee: Ferring International Center SA
    Inventors: Ian Cottingham, Daniel Plaksin, Richard Boyd White
  • Pharmaceutical preparation comprising recombinant HcG
    Patent number: 9676835
    Abstract: The present disclosure describes recombinant human chorionic gonadotropin (hCG) and methods for the production thereof. The recombinant hCG can include ?2,3, ?2,6, and, optionally, ?2,8 sialylation. The recombinant hCG can be produced in a human cell line such as a PER.C6® cell line.
    Type: Grant
    Filed: May 21, 2014
    Date of Patent: June 13, 2017
    Assignee: Ferring B.V.
    Inventors: Ian Cottingham, Daniel Plaksin, Richard Boyd White
  • Recombinant FSH including alpha 2,3- and alpha 2,6-sialylation
    Patent number: 9546204
    Abstract: Preparations including recombinant FSH (rFSH).
    Type: Grant
    Filed: November 14, 2014
    Date of Patent: January 17, 2017
    Assignee: Ferring International Center SA
    Inventors: Ian Cottingham, Daniel Plaksin, Richard Boyd White
  • PHARMACEUTICAL PREPARATION
    Publication number: 20160347811
    Abstract: Preparations including recombinant FSH (rFSH).
    Type: Application
    Filed: August 16, 2016
    Publication date: December 1, 2016
    Inventors: Ian Cottingham, Daniel Plaksin, Richard Boyd White
  • Pharmaceutical preparation comprising recombinant hCG
    Patent number: 8975226
    Abstract: The present disclosure describes recombinant human chorionic gonadotropin (hCG) and methods for the production thereof. The recombinant hCG can include ?2,3, ?2,6, and, optionally, ?2,8 sialylation. The recombinant hCG can be produced in a human cell line such as a PER.C6® cell line.
    Type: Grant
    Filed: October 4, 2010
    Date of Patent: March 10, 2015
    Assignee: Ferring B.V.
    Inventors: Ian Cottingham, Daniel Plaksin, Richard Boyd White
  • Recombinant FSH Including Alpha 2,3- and Alpha 2,6-Sialylation
    Publication number: 20150065695
    Abstract: Preparations including recombinant FSH (rFSH).
    Type: Application
    Filed: November 14, 2014
    Publication date: March 5, 2015
    Inventors: Ian Cottingham, Daniel Plaksin, Richard Boyd White
  • Recombinant FSH including alpha 2,3- and alpha 2,6-sailylation
    Patent number: 8951967
    Abstract: The present disclosure describes recombinant follicle stimulating hormone (FSH) and methods for the production thereof. The recombinant FSH can include ?2,3, ?2,6, and, optionally, ?2,8 sialylation. The recombinant FSH can be produced in a human cell line such as a PER.C6® cell line.
    Type: Grant
    Filed: April 16, 2009
    Date of Patent: February 10, 2015
    Assignee: Ferring International Center SA
    Inventors: Ian Cottingham, Daniel Plaksin, Richard Boyd White
  • Pharmaceutical Preparation Comprising Recombinant HcG
    Publication number: 20140249082
    Abstract: The present disclosure describes recombinant human chorionic gonadotropin (hCG) and methods for the production thereof. The recombinant hCG can include ?2,3, ?2,6, and, optionally, ?2,8 sialylation. The recombinant hCG can be produced in a human cell line such as a PER.C6® cell line.
    Type: Application
    Filed: May 21, 2014
    Publication date: September 4, 2014
    Applicant: Ferring B.V.
    Inventors: Ian Cottingham, Daniel Plaksin, Richard Boyd White
  • Pharmaceutical Preparation Comprising Recombinant HCG
    Publication number: 20130023476
    Abstract: Preparations including recombinant hCG (r hCG).
    Type: Application
    Filed: October 4, 2010
    Publication date: January 24, 2013
    Applicant: FERRING B.V.
    Inventors: Ian Cottingham, Daniel Plaksin, Richard Boyd White
  • RECOMBINANT FSH INCLUDING ALPHA 2,3- AND ALPHA 2,6-SAILYLATIO
    Publication number: 20110105398
    Abstract: Preparations including recombinant FSH (rFSH).
    Type: Application
    Filed: April 16, 2009
    Publication date: May 5, 2011
    Applicant: Ferring International Center SA
    Inventors: Ian Cottingham, Daniel Plaksin, Richard Boyd White